News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Daily News Reduced EF Evident in Some Elite Endurance Athletes Michael O'Riordan December 21, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Daily News CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests Yael L. Maxwell December 13, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
News Daily News Fewer Adverse Events with Radial vs. Femoral PCI in High-Risk IABP Patients Jason Kahn October 25, 2013